Kyle D. Kuvalanka SEC EDGAR Filings (CIK 0001638904)

SEC EDGAR filings, ownership reports, and insider transactions for Kyle D. Kuvalanka.

Business address
Blueprint Medicines Corp., 215 First Street, Suite 340/350, Cambridge, MA, 02142
Get insider transactions for this reporting owner
Kyle D. Kuvalanka has filed 4 SEC EDGAR filings since 30 Apr 2015

Latest Filings

Recent SEC filings for Kyle D. Kuvalanka including 3, 4.

Form type Document Filing Description Filing date Reporting date File number(s)
3 Open 3 document View SEC filing for 3 3 08 Jan 2026 08 Jan 2026 001-43047
4 Open 4 document View SEC filing for 4 FORM 4 - 13 Feb 2017 10 Feb 2017 001-37813
3 Open 3 document View SEC filing for 3 3 29 Jun 2016 29 Jun 2016 001-37813
3 Open 3 document View SEC filing for 3 3 30 Apr 2015 30 Apr 2015 001-37359

About this filer

Kyle D. Kuvalanka files with the SEC under CIK 0001638904. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages